HEXASONIUM

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	RACEMIC
Molecular Formula	C18H27O2S
Molecular Weight	307.471
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	1

SHOW SMILES / InChI

Structure of HEXASONIUM

Structure Search

SMILES

C[S+](C)CCOC(=O)C(C1CCCCC1)C2=CC=CC=C2

InChI

InChIKey=NRZPIZQZOQMVFZ-UHFFFAOYSA-N

InChI=1S/C18H27O2S/c1-21(2)14-13-20-18(19)17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3,5-6,9-10,16-17H,4,7-8,11-14H2,1-2H3/q+1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8517078

Hexasonium, an anticholinergic agent, was studied as a spasmolytic. Information about the current use of this drug is not available.

Approval Year

Name

Type

Language

HEXASONIUM

Common Name

English

HEXASONIUM CATION

Common Name

English

HEXASONIUM ION

Common Name

English

Hexasonium [WHO-DD]

Common Name

English

SULFONIUM, (2-((2-CYCLOHEXYL-2-PHENYLACETYL)OXY)ETHYL)DIMETHYL-

Systematic Name

English

Code System Code Type Description

EVMPD

SUB02508MIG

Created by admin on Sat Dec 16 04:51:39 GMT 2023 , Edited by admin on Sat Dec 16 04:51:39 GMT 2023

PRIMARY

CAS

25330-82-9

Created by admin on Sat Dec 16 04:51:39 GMT 2023 , Edited by admin on Sat Dec 16 04:51:39 GMT 2023

PRIMARY

PUBCHEM

71526

Created by admin on Sat Dec 16 04:51:39 GMT 2023 , Edited by admin on Sat Dec 16 04:51:39 GMT 2023

PRIMARY

FDA UNII

N456Q41XF9

Created by admin on Sat Dec 16 04:51:39 GMT 2023 , Edited by admin on Sat Dec 16 04:51:39 GMT 2023

PRIMARY

SMS_ID

100000086700

Created by admin on Sat Dec 16 04:51:39 GMT 2023 , Edited by admin on Sat Dec 16 04:51:39 GMT 2023

PRIMARY

ACTIVE MOIETY


					N456Q41XF9